The AAP, the American Academy of Child and Adolescent Psychiatry (AACAP) and Children’s Hospital Association (CHA) are calling on federal officials to lead discussions and identify solutions for ongoing shortages of stimulants and other medications that impact child health. A letter sent by the three organizations to the U.S. Department of Health and Human Services and Drug Enforcement Administration asks the federal government to “convene all relevant stakeholders for a forum to discuss the impact these shortages are having on patients, families and their providers and identify actionable solutions that will alleviate these shortages.”